应用OCT观察Lucentis治疗视网膜静脉阻塞性黄斑水肿的疗效  

The Clinical Study on Intravitreous Injection of Lucentis For Macular Edema in Retinal Vein Occlusion by OCT

作　　者：李臻 

机构地区：[1]内蒙古自治区人民医院眼科,内蒙古呼和浩特010017

出　　处：《内蒙古医学杂志》2013年第10期1167-1170,F0004,共5页Inner Mongolia Medical Journal

摘　　要：目的:观察玻璃体腔注射Lucentis治疗视网膜静脉阻塞继发黄斑水肿的疗效。方法:回顾性分析玻璃体腔注射Lucentis治疗视网膜静脉阻塞性黄斑水肿患者44例(44眼),定期随访6个月。观察治疗前及治疗后1d,2周,1、3、6个月时最佳矫正视力,OCT显示的黄斑中心凹厚度变化及并发症。结果:Lucentis玻璃体腔注射2周,1、3、6个月平均最佳矫正视力均提高,差异有统计学意义(P<0.05)。随访中未见与注射及药物有关的眼部及全身不良反应。结论:Lucentis玻璃体腔注射治疗视网膜静脉阻塞引起的黄斑水肿安全有效,操作简单,必要时可重复注射治疗。Objective： To observe the curative effect of intravitreal injection of Lucentis for treatment of retinal vein occlusion（RVO） with macular edema（ME）. Methods： This is a retrospective study on 44 cases （44 eyes） with macular edema induced by RVO. All of the patients received intravitreous injection of lucentis, andwere regular followed up for 6 months. To observe the BCVA, CMT and complications before injection and 1 day, 2 weeks, and 1,3, 6months after initial injection. Results：The mean BCVA was significantly improved at 2 weeks and 1, 3, 6 months after injection in comparison with before injection（p 〈 0.05）. No ocular or systemic adverse events were found after intravitreal injection of lucentis during the follow- up duration. Conclusion： In- travitreous injection of lucentis for ME in RVO is safe, effective and simole operation.

关 键 词：LUCENTIS 视网膜静脉阻塞 黄斑水肿 

分 类 号：R774[医药卫生—眼科]